These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31206638)

  • 1. Risk of breast cancer by prior screening results among women participating in BreastScreen Norway.
    Lilleborge M; Falk RS; Russnes H; Sauer T; Ursin G; Hofvind S
    Cancer; 2019 Oct; 125(19):3330-3337. PubMed ID: 31206638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interval Breast Cancer Rates and Histopathologic Tumor Characteristics after False-Positive Findings at Mammography in a Population-based Screening Program.
    Hofvind S; Sagstad S; Sebuødegård S; Chen Y; Roman M; Lee CI
    Radiology; 2018 Apr; 287(1):58-67. PubMed ID: 29239711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI.
    Vreemann S; van Zelst JCM; Schlooz-Vries M; Bult P; Hoogerbrugge N; Karssemeijer N; Gubern-Mérida A; Mann RM
    Breast Cancer Res; 2018 Aug; 20(1):84. PubMed ID: 30075794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Number of prior negative screening outcomes does not influence future risk of breast cancer.
    Lilleborge M; Falk RS; Hofvind S
    Eur J Epidemiol; 2020 Jun; 35(6):549-556. PubMed ID: 32430839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency and diagnostic outcome of bilateral recall at screening mammography.
    Lameijer JRC; Nederend J; Voogd AC; Tjan-Heijnen VCG; Duijm LEM
    Int J Cancer; 2021 Jan; 148(1):48-56. PubMed ID: 32621785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in frequency and outcome of high-risk breast lesions at core needle biopsy in women recalled at biennial screening mammography, a multiinstitutional study.
    Luiten JD; Korte B; Voogd AC; Vreuls W; Luiten EJT; Strobbe LJ; Rutten MJCM; Plaisier ML; Lohle PN; Hooijen MJH; Tjan-Heijnen VCG; Duijm LEM
    Int J Cancer; 2019 Nov; 145(10):2720-2727. PubMed ID: 31001821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and radiological features of breast tumors according to history of false-positive results in mammography screening.
    Domingo L; Romero A; Blanch J; Salas D; Sánchez M; Rodríguez-Arana A; Ferrer J; Ibáñez J; Vega A; Laso MS; Castells X; Sala M
    Cancer Epidemiol; 2013 Oct; 37(5):660-5. PubMed ID: 23962702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early performance measures following regular versus irregular screening attendance in the population-based screening program for breast cancer in Norway.
    Thy JE; Larsen M; Vigeland E; Koch H; Hovda T; Hofvind S
    J Med Screen; 2024 Jun; 31(2):107-114. PubMed ID: 37691575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of radiation-induced breast cancers due to biennial mammographic screening in women aged 50-69 years is minimal.
    Hauge IH; Pedersen K; Olerud HM; Hole EO; Hofvind S
    Acta Radiol; 2014 Dec; 55(10):1174-9. PubMed ID: 24311702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing screening mammography for early breast cancer detection in Vermont and Norway.
    Hofvind S; Vacek PM; Skelly J; Weaver DL; Geller BM
    J Natl Cancer Inst; 2008 Aug; 100(15):1082-91. PubMed ID: 18664650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cumulative risk of false-positive results in the Norwegian Breast Cancer Screening Program: updated results.
    Roman M; Hubbard RA; Sebuodegard S; Miglioretti DL; Castells X; Hofvind S
    Cancer; 2013 Nov; 119(22):3952-8. PubMed ID: 23963877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term risk of screen-detected and interval breast cancer after false-positive results at mammography screening: joint analysis of three national cohorts.
    Román M; Hofvind S; von Euler-Chelpin M; Castells X
    Br J Cancer; 2019 Jan; 120(2):269-275. PubMed ID: 30563993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence, Characteristics, and Outcomes of Interval Breast Cancers Compared With Screening-Detected Breast Cancers.
    Niraula S; Biswanger N; Hu P; Lambert P; Decker K
    JAMA Netw Open; 2020 Sep; 3(9):e2018179. PubMed ID: 32975573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance measures among non-immigrants and immigrants attending BreastScreen Norway: a population-based screening programme.
    Bhargava S; Akslen LA; Bukholm IRK; Hofvind S
    Eur Radiol; 2019 Sep; 29(9):4833-4842. PubMed ID: 30762109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated Volumetric Analysis of Mammographic Density in a Screening Setting: Worse Outcomes for Women with Dense Breasts.
    Moshina N; Sebuødegård S; Lee CI; Akslen LA; Tsuruda KM; Elmore JG; Hofvind S
    Radiology; 2018 Aug; 288(2):343-352. PubMed ID: 29944088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Participation and cancer detection after reminders versus ordinary invitations in BreastScreen Norway.
    Thy JE; Vigeland E; Larsen M; Hofvind S
    J Med Screen; 2022 Sep; 29(3):178-184. PubMed ID: 35502849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screen-detected and interval breast cancer after concordant and discordant interpretations in a population based screening program using independent double reading.
    Martiniussen MA; Sagstad S; Larsen M; Larsen ASF; Hovda T; Lee CI; Hofvind S
    Eur Radiol; 2022 Sep; 32(9):5974-5985. PubMed ID: 35364710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot trial of digital breast tomosynthesis (3D mammography) for population-based screening in BreastScreen Victoria.
    Houssami N; Lockie D; Clemson M; Pridmore V; Taylor D; Marr G; Evans J; Macaskill P
    Med J Aust; 2019 Oct; 211(8):357-362. PubMed ID: 31448816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammographic features and risk of breast cancer death among women with invasive screen-detected cancer in BreastScreen Norway 1996-2020.
    Moshina N; Backmann HA; Skaane P; Hofvind S
    Eur Radiol; 2024 May; 34(5):3364-3374. PubMed ID: 37935848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.